Joshua
Young Yang
Entrepreneur & Bioengineer
Current
· Co-founder of Nephrosant, a Series A Biotechnology Diagnostics Startup
· Venture Capital Fellow @ Pear Ventures,
SeaX Ventures, and InSITE
· Scientific & Medical Writer @ Doximity’s Op-Med & KevinMD
Education
· MBA candidate @ Stanford University Graduate School of Business
· MD-PhD candidate @ Johns Hopkins University School of Medicine and Department of Bioengineering
· M.Eng. in Translational Medicine @ UC San Francisco and UC Berkeley
·
B.S. in Bioengineering: Biotechnology and B.S. in General Biology @ UC San Diego
Links
· Email: joshyang@stanford.edu
· Twitter: @joshuayoungyang
· Professional
Profile: LinkedIn
· Academic Publications: Google Scholar
· Curriculum
Vitae: CV
· Professional Baking: Instagram
September 2020
· I was selected as a Siebel Scholar Class of 2021,
an honor recognizing the most talented students at the world’s leading graduate schools of business, computer science, bioengineering, and energy science.
June 2020
·
My team and I won 1st place at the Merck Innovation Cup 2020 for our proposal for a novel drug discovery platform, having been
selected out of over 2,000 applicants.
· My perspective piece titled, A Pandemic of Loneliness, was published in Doximity's Op-Med.
·
My article on how to find fellowships and scholarships for graduate school was published by Sallie Mae on their Within Reach
blog.
April 2020
· Our global health project Cerviscope won 2nd place at the Johns Hopkins Healthcare Design Competition and was a finalist for the Bisciotti
Student Entrepreneurship Award
March 2020
· My first-author publication on Nephrosant's QiSant Assay was published in Science Translational Medicine
· My startup Nephrosant and I were featured in GenomeWeb about
the upcoming launch of our QiSant assay.
· I was featured in Poets & Quants 'Meet Stanford GSB's MBA Class of 2021'